|
Press
Releases January
15, 2005 - Bristol Investment Group expands focus on healthcare
financings and investment research services
NEW YORK - Bristol
Investment Group, a leading private investment banking firm, has
increased its financing activities for biotech / healthcare companies.
Over the past year Bristol has successfully raised long term growth
capital for public and private healthcare companies. Our success
is based on a deep understanding of the industry and strong relationships
with investors in this area. Bristol’s brochure covering its
healthcare focus is available by clicking here: Our relationship
with institutional investors in healthcare companies is enhanced
through the research we provide to these investors. Christopher
P. Moore, CFA is our Director of Research who covers health care
companies. Mr. Moore has written extensive research on healthcare
companies and his stock picks have performed very well. Mr. Moore
has fifteen years experience analyzing and working with small growth
companies. "Chris
has extensive healthcare financial analysis and investment knowledge
and has found many attractive healthcare companies which are undervalued
in the market," said Alan Donenfeld, President of Bristol Investment
Group. Mr. Moore expects many small cap companies in biotech, healthcare
services and medical devices will grow rapidly and produce significant
increases in value. Mr. Moore commented, “I am quite pleased
with the continued growth of several healthcare companies that I
follow. Our affiliation with Wall Street Advisor LLC (www.WallStreetAdvisor.com)
will expand our coverage and ability to distribute research to a
large number of healthcare focused investors.” About
Bristol Investment Group, Inc.
Bristol
Investment Group, Inc. is a private investment banking firm focused
on serving the needs of high growth public and private companies
who require capital, strategic planning and merger and acquisition
advice. The members of the firm have a broad range of experience
in raising debt and equity capital, structuring and financing acquisitions,
arranging joint ventures and managing companies. Mr. Alan Donenfeld,
President of Bristol, formed the company in 1990 with the mission
of providing a high standard of investment banking services to small
and middle market public and private companies. Bristol is a broker/dealer
firm registered with the National Association of Securities Dealers
(NASD) and is member of the Securities Investor Protection Corporation
(SIPC). For more information on Bristol Investment Group call 212-572-6306
or visit www.BristolDirect.com
website. |
||||||